TERBINORM spray overcome fungus easy!

Today, when choosing a drug in a pharmacy, the buyer is focused on the price segment, so brands that are optimal in terms of pharmacoeconomic characteristics deserve more and more attention. TERBINORM spray (Rotapharm, Romania) fully meets these qualities.

The active substance of TERBINORM spray – terbinafine – determines a wide spectrum of antifungal activity. The site of application of terbinafine is the cytoplasmic membranes of fungal cells. Terbinafine acts at the earliest stages of sterol metabolism, inhibiting squalene epoxidase, on the one hand, it inhibits the formation of the main component of the fungal cell wall – ergosterol, as a result of which the cytoplasmic membranes of fungal cells are disrupted, and on the other hand, promotes the accumulation of squalene. Thus, the effect of terbinafine on fungal cells is twofold – fungistatic and fungicidal.

TERBINORM spray has proven itself in the treatment of fungal infections of the skin, including athlete’s foot, athlete’s groin, fungal infections of the smooth skin of the body caused by dermatophytes, and yeast infections of the skin caused by fungi of the genus Candida, in particular – diaper rash.

Chernyaeva Elena, leading specialist in pharmacovigilance and clinical trials

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design